Psy95 - Exploring the Potential Cost-Effectiveness of Emicizumab for Hemophilia a With Inhibitor in Italy

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2670
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Psy42 - Exploring the Potential Budget Impact of Emicizumab for Hemophilia a With Inhibitor in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Exploring the Potential Cost-Effectiveness of a Vocational Rehabilitation Program for Individuals With Schizophrenia in a High-Income Welfare Society

BMC Psychiatry
PsychiatryMental Health
2019English

Psy223 - Qualitative Research in Haemophilia A: Emicizumab Transforms Lifestyle of Patients With Inhibitor

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

2019 Appendix Edition: Hemostatic Treatment Guidelines for Hemophilia Patients the Use of Hemlibra® (Emicizumab)

Japanese Journal of Thrombosis and Hemostasis
2020English

Psy57 - A Comparison Between on Demand Usage of Rfviia vs Prophylaxis Use of Emicizumab in High Titer Inhibitory Hemophilia a Patients in Iran; A Cost Utility Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Successful Use of Emicizumab in a Patient With Refractory Acquired Hemophilia a and Acute Coronary Syndrome Requiring Percutaneous Coronary Intervention

Research and Practice in Thrombosis and Haemostasis
2019English

Psy58 - Budget Impact Analysis of Emicizumab in Pediatric Hemophilia a Patients With Inhibitors in the Ministry of Health (Moh), Kingdom of Saudi Arabia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of a Potential Zika Vaccine Candidate: A Case Study for Colombia

BMC Medicine
Medicine
2018English

Improving the Performance of Factor VIII Inhibitor Tests in Hemophilia A

Thrombosis Research
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy